These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 37767966)
1. Letter to the editor regarding "Understanding subjective experience in psychedelic-assisted psychotherapy: The need for phenomenology". Ventura B Aust N Z J Psychiatry; 2024 Jan; 58(1):92-93. PubMed ID: 37767966 [No Abstract] [Full Text] [Related]
2. Author reply to Letter to the Editor regarding 'Understanding subjective experience in psychedelic-assisted psychotherapy: The need for phenomenology'. Miceli McMillan R; Fernandez AV Aust N Z J Psychiatry; 2024 Jan; 58(1):93-94. PubMed ID: 37927156 [No Abstract] [Full Text] [Related]
3. Understanding subjective experience in psychedelic-assisted psychotherapy: The need for phenomenology. Miceli McMillan R; Fernandez AV Aust N Z J Psychiatry; 2023 Jun; 57(6):783-788. PubMed ID: 36384307 [TBL] [Abstract][Full Text] [Related]
5. Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin. Carhart-Harris RL; Leech R; Williams TM; Erritzoe D; Abbasi N; Bargiotas T; Hobden P; Sharp DJ; Evans J; Feilding A; Wise RG; Nutt DJ Br J Psychiatry; 2012 Mar; 200(3):238-44. PubMed ID: 22282432 [TBL] [Abstract][Full Text] [Related]
6. Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history. Pearson C; Siegel J; Gold JA J Neurol Sci; 2022 Mar; 434():120096. PubMed ID: 34942586 [TBL] [Abstract][Full Text] [Related]
7. Psychedelic-assisted psychotherapy for the treatment of major depression: a synthesis of phenomenological explanations. Miceli McMillan R; Jordens C Med Health Care Philos; 2022 Jun; 25(2):225-237. PubMed ID: 35064398 [TBL] [Abstract][Full Text] [Related]
8. Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy. Hendricks PS Int Rev Psychiatry; 2018 Aug; 30(4):331-342. PubMed ID: 30260256 [TBL] [Abstract][Full Text] [Related]
9. Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences? Majić T; Schmidt TT; Gallinat J J Psychopharmacol; 2015 Mar; 29(3):241-53. PubMed ID: 25670401 [TBL] [Abstract][Full Text] [Related]
10. Compassionate use of psychedelics. Greif A; Šurkala M Med Health Care Philos; 2020 Sep; 23(3):485-496. PubMed ID: 32468195 [TBL] [Abstract][Full Text] [Related]
11. Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects. Rosenblat JD; Leon-Carlyle M; Ali S; Husain MI; McIntyre RS Am J Psychiatry; 2023 May; 180(5):395-396. PubMed ID: 36945824 [No Abstract] [Full Text] [Related]
12. Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy. Horton DM; Morrison B; Schmidt J Am J Psychother; 2021 Dec; 74(4):140-149. PubMed ID: 34293927 [TBL] [Abstract][Full Text] [Related]
13. The Emerging Field of Psychedelic Psychotherapy. Barber GS; Aaronson ST Curr Psychiatry Rep; 2022 Oct; 24(10):583-590. PubMed ID: 36129571 [TBL] [Abstract][Full Text] [Related]
14. Psychedelic-assisted psychotherapy, patient vulnerability and abuses of power. Meikle S; Carter O; Bedi G Aust N Z J Psychiatry; 2024 Feb; 58(2):104-106. PubMed ID: 37767944 [No Abstract] [Full Text] [Related]
15. Psilocybin-assisted therapy for depression: How do we advance the field? Meikle SE; Liknaitzky P; Rossell SL; Ross M; Strauss N; Thomas N; Murray G; Williams M; Castle DJ Aust N Z J Psychiatry; 2020 Mar; 54(3):225-231. PubMed ID: 31752499 [TBL] [Abstract][Full Text] [Related]
16. The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice. Stein CA; Penn A; Van Hope S; Dorsen CG; Mangini M J Midwifery Womens Health; 2022 May; 67(3):373-383. PubMed ID: 35522087 [TBL] [Abstract][Full Text] [Related]